← Eichor
Study identifier: NCT06943781 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection

Condition: Gastric Adenocarcinoma · Helicobacter Pylori  ·  Sponsor: Fudan University

PhaseN/A
Planned participants15000
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersYes

About this study

This is a prospective study designed to compare the performance of fecal H. pylori gastric cancer susceptibility analysis and the gastric cancer risk questionnaire for the early detection of gastric cancer. The primary objective is to assess whether each method, individually or in combination, can facilitate earlier diagnosis of gastric cancer. All participants will undergo fecal H. pylori gastric cancer susceptibility testing and complete the gastric cancer risk questionnaire.

This description comes directly from the study's public registry record.

Talk to the study team

Dazhi Xu, PhD  ·  86-18121299796  ·  xudzh@fudan.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

People's Hospital of Tongling CityTongling, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06943781